Enanta Pharmaceuticals Inc. has announced that its 2026 Annual Meeting of Stockholders will be held virtually on March 11, 2026. During the meeting, shareholders will vote on the election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and the approval of an amendment to Enanta's 2019 Equity Incentive Plan to increase the number of shares available under the plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-022558), on January 26, 2026, and is solely responsible for the information contained therein.